Hasil Pencarian - Guilherme Nader-Marta

  • Menampilkan 1 - 13 hasil dari 13
Perbaiki Hasil
  1. 1
    2023 Year in review: Early breast cancer

    2023 Year in review: Early breast cancer oleh Guilherme Nader-Marta, Ann H. Partridge

    Diterbitkan 2024-04-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  2. 2
    Immune thrombocytopenia and autoimmune thyroid disease: a controversial overlap

    Immune thrombocytopenia and autoimmune thyroid disease: a controversial overlap oleh Guilherme Nader Marta, Fernando Peixoto Ferraz de Campos

    Diterbitkan 2015-06-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  3. 3
    Antibody–drug conjugates: the evolving field of targeted chemotherapy for breast cancer treatment

    Antibody–drug conjugates: the evolving field of targeted chemotherapy for breast cancer treatment oleh Guilherme Nader-Marta, Chiara Molinelli, Véronique Debien, Diogo Martins-Branco, Philippe Aftimos, Evandro de Azambuja, Ahmad Awada

    Diterbitkan 2023-07-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  4. 4
    Efficacy and safety of sorafenib in elderly patients with advanced hepatocellular carcinoma

    Efficacy and safety of sorafenib in elderly patients with advanced hepatocellular carcinoma oleh Guilherme Nader Marta, Leonardo G. da Fonseca, Maria Ignez Braghiroli, Fernando Moura, Paulo M. Hoff, Jorge Sabbaga

    Diterbitkan 2021-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  5. 5
    Trends in Melanoma Mortality in Brazil: A Registry-Based Study

    Trends in Melanoma Mortality in Brazil: A Registry-Based Study oleh Guilherme Nader Marta, Rodrigo Ramella Munhoz, Monica La Porte Teixeira, Bernadette Cunha Waldvogel, Veridiana Pires de Camargo, Olavo Feher, Jose Antonio Sanches

    Diterbitkan 2020-11-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  6. 6
    Safety and efficacy of cytotoxic chemotherapy in hepatocellular carcinoma after first-line treatment with sorafenib

    Safety and efficacy of cytotoxic chemotherapy in hepatocellular carcinoma after first-line treatment with sorafenib oleh Leonardo Gomes da Fonseca, Guilherme Nader Marta, Maria Ignez Freitas Melro Braghiroli, Aline Lopes Chagas, Flair Jose Carrilho, Paulo Marcelo Hoff, Jorge Sabbaga

    Diterbitkan 2018-12-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  7. 7
    Treatment priorities in oncology: do we want to live longer or better?

    Treatment priorities in oncology: do we want to live longer or better? oleh Guilherme Nader Marta, Luís G. Del Nero, Gustavo Nader Marta, Andrea Mangabeira, Gabriela Critchi, Maria J. Kovács, João Luis Fernandes da Silva, Everardo D. Saad

    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  8. 8
    Analysis of Efficacy and Toxicity Profile of First-Line Sunitinib or Pazopanib in Metastatic Clear Cell Renal Cell Carcinoma in the Brazilian Population

    Analysis of Efficacy and Toxicity Profile of First-Line Sunitinib or Pazopanib in Metastatic Clear Cell Renal Cell Carcinoma in the Brazilian Population oleh Pedro Isaacsson Velho, Mirella Nardo, Manoel Carlos Leonardi de Azevedo Souza, Renata R.C. Colombo Bonadio, Guilherme Nader Marta, David Q.B. Muniz, Diogo Assed Bastos, Carlos Dzik

    Diterbitkan 2018-09-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  9. 9
    First-in-human study of SBRT and adenosine pathway blockade to potentiate the benefit of immunochemotherapy in early-stage luminal B breast cancer: results of the safety run-in phase of the Neo-CheckRay trial

    First-in-human study of SBRT and adenosine pathway blockade to potentiate the benefit of immunochemotherapy in early-stage luminal B breast cancer: results of the safety run-in pha... oleh Martine Piccart-Gebhart, Emanuela Romano, Christos Sotiriou, Marianne Paesmans, Ligia Craciun, Denis Larsimont, Roberto Salgado, Elisa Agostinetto, Laurence Buisseret, Isabelle Veys, Alex de Caluwé, Philip Poortmans, Andrea Gombos, Guilherme Nader Marta, Zoe Denis, Stylianos Drisis, Christophe Vandekerkhove, Antoine Desmet, Catherine Philippson, Dirk Van Gestel, Michail Ignatiadis

    Diterbitkan 2023-12-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  10. 10
    Brazilian Validation of the European Organisation for Research and Treatment of Cancer (EORTC) Quality of Life Group (QLG) Computerised Adaptive Tests (CAT) Core

    Brazilian Validation of the European Organisation for Research and Treatment of Cancer (EORTC) Quality of Life Group (QLG) Computerised Adaptive Tests (CAT) Core oleh Gustavo Nader Marta, Tomás Y. T. de Souza, Alice R. N. de Souza e Silva, Ana Paula A. Pereira, David R. Ferreira Neto, Rie N. Asso, Fabiana A. M. Degrande, Guilherme Nader-Marta, Maurício F. da Silva, Rafael Gadia, Samir A. Hanna, Bernhard Holzner, Everardo D. Saad, Morten Aagaard Petersen

    Diterbitkan 2021-08-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  11. 11
    Clinical characterization, prognostic, and predictive values of HER2-low in patients with early breast cancer in the PALLAS trial (ABCSG-42/AFT-05/BIG-14–13/PrE0109)

    Clinical characterization, prognostic, and predictive values of HER2-low in patients with early breast cancer in the PALLAS trial (ABCSG-42/AFT-05/BIG-14–13/PrE0109) oleh Guilherme Nader-Marta, Christian Singer, Dominik Hlauschek, Angela DeMichele, Paolo Tarantino, Evandro de Azambuja, Georg Pfeiler, Miguel Martin, Justin M. Balko, Zbigniew Nowecki, Marija Balic, Adam M. Brufsky, Arlene Chan, Patrick G. Morris, Tufia Haddad, Sibylle Loibl, Yuan Liu, Lidija Soelkner, Christian Fesl, Erica L. Mayer, Michael Gnant, on behalf of the PALLAS groups and investigators

    Diterbitkan 2024-10-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  12. 12
    Outcomes and Prognostic Factors in a Large Cohort of Hospitalized Cancer Patients With COVID-19

    Outcomes and Prognostic Factors in a Large Cohort of Hospitalized Cancer Patients With COVID-19 oleh Guilherme Nader Marta, Renata Colombo Bonadio, Odeli Nicole Encinas Sejas, Gabriel Watarai, Maria Cecilia Mathias Machado, Lorena Teixeira Frasson, Camila Motta Venchiarutti Moniz, Raquel Keiko de Luca Ito, Driele Peixoto, Camilla Oliveira Hoff, Veruska Menegatti Anastacio, Ulysses Ribeiro, Juliana Pereira, Vanderson Rocha, Edson Abdala, Maria Del Pilar Estevez-Diz, Paulo M. Hoff

    Diterbitkan 2021-12-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  13. 13
    Updated Brazilian guidelines for the management of immune-related adverse events associated with checkpoint inhibitors - edition 2.0

    Updated Brazilian guidelines for the management of immune-related adverse events associated with checkpoint inhibitors - edition 2.0 oleh Rodrigo Ramella Munhoz, Clarissa Maria de Cerqueira Mathias, Guilherme Harada, Aknar Calabrich, Alberto Julius Wainstein, Andréia Cristina de Melo, Antonio Carlos Buzaid, Artur Katz, Carlos Gil Ferreira, Carlos Henrique dos Anjos, Clarissa Baldotto, Clarissa Maria de Cerqueira Mathias, Elimar Elias Gomes, Fernando Moura, Gilberto de Castro, Guilherme Harada, Guilherme Nader Marta, Gustavo dos Santos Fernandes, Luiza Dib Batista Bugiato Faria, Mariana Laloni, Paulo Marcelo Gehm Hoff, Rodrigo Ramella Munhoz, Romualdo Barroso-Sousa, Sergio Jobim de Azevedo, Vladmir Cláudio Cordeiro de Lima, William Nassib William

    Diterbitkan 2022-10-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:

Alat Pencarian: